The News
S&P at the verge of entering Bear Territory, Tuesday 10-04-2011
DNDN - Dendreon Corporation is a biotechnology company focused on therapeutics that may improve cancer treatment options for patients.
The company's Flagship drug -PROVENGE- approved by the FDA for the treat of prostate cancer. This is a very expensive treatment, obviously very lucrative for the company. There are some issues concerning the payment from the Medicare for this expensive treatment that is what brought the Stock to 52WK LOWS.
We believe even if the payments from the Medicare are reduced, still the payments would be significant, also, the company has other drugs under development for the treatment of ovarian, breast and bladder cancers/tumors. We think at this level the stock is under valued and could bounce back fast, must be on your watch list.
You are missing the Premium Alerts!Sign-up, Get Alerts that MakeMoney!®
we get compensated by the companies we feature.Always Read the full Disclosure/Disclaimer. Thanks
Hot stocks to Watch COOL, FCEL, CVVT,10-03-2011
COOL - Majesco Entertainment Company produces family oriented video games.The Company sells its products primarily to large retail chains, specialty retail stores, video game rental outlets and distributors. Very Attractive.
FCEL - FuelCell Energy makes stationary fuel cells for commercial, industrial, government and utility customers. The Company provide generation baseload power. Its Direct FuelCell (DFC) power plants are generating power at over 50 locations worldwide. Very Attractive.
CVVT - China Valves manufactures metal valves. The Company makes over 800 models with more than 10,000 specifications of low, medium and high-pressure valves according to differing standards and specifications. Valves ranging from 3 millimeter to 1,300 millimeter and with pressure caps that range from 150 pounds to 4,500 pounds. Under Valued
You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®
we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks
Hot Stocks to Watch GERN, CYTX, Friday 09-30-2011
GERN - Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. It develops a range of anti-cancer therapies based on telomerase inhibitors and telomerase therapeutic vaccines; and diagnostics based on telomerase detection as a marker for cancer diagnosis, prognosis, patient monitoring, and screening. Very Attractive, Bouncing Back, Just appointed a New CEO.
CYTX - Cytori Therapeutics is engaged in the development of medical products to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function. Its principal products include the Celution family of products. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzyme reagents, and related instrumentation. Attractive, Bouncing Back from 52WK Lows.
You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®
we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks
Hot Stocks to Watch ANAD, SIGA, Thursday 09-29-2011
ANAD – ANADIGICS provides semiconductor solutions to the broadband wireless and wireline communications markets. Its products include radio frequency (RF) power amplifiers (PAs), tuner integrated circuits, active splitters, line amplifiers, and other components.
ANAD provides RF power amplifiers for the fourth generation (4G) wireless services, including long term evolution (LTE), WiMAX and WiFi products for wireless mobile devices. Under valued, Bouncing Back from 52WK Lows.
SIGA - SIGA Technologies is a bio-defense company developing novel products for the prevention and treatment of infectious diseases. Its products are also used in defense against biological warfare agents comprising smallpox and arenaviruses.
SIGA offers broad spectrum antiviral candidates against viruses in the Poxviridae, Filoviridae, Bunyaviridae, Arenaviridae, Flaviviridae, Togaviridae, Retroviridae, and Picornaviridae families. Further, it has four drug series in the pre-clinical development stage against four serotypes of virus.Very Attractive, Bouncing back from 52WK Lows.
You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®
we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks
OTCKing
Feed Entries
